{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:03:47Z","timestamp":1784685827729,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology Innovation Action Plan\u201d Basic Research Project of Shanghai Science and Technology Commission","award":["No. 23JC1403002"],"award-info":[{"award-number":["No. 23JC1403002"]}]},{"name":"Medical Key Subject of Jinshan District","award":["No. JSZK2023H01"],"award-info":[{"award-number":["No. JSZK2023H01"]}]},{"name":"Key Subject Development Project of Jinshan Hospital of Fudan University - Obstetrics and Gynecology","award":["No. ZDXK-2025-6"],"award-info":[{"award-number":["No. ZDXK-2025-6"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-01967-0","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:00:17Z","timestamp":1784685617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics identification of SPON1-related risk model for predicting prognosis and drug response in ovarian cancer"],"prefix":"10.1007","volume":"26","author":[{"given":"Zouyu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liansuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"16","key":"1967_CR1","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC (2020) The tumor microenvironment. Curr Biol 30(16):R921\u2013R925","journal-title":"Curr Biol"},{"key":"1967_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217772","volume":"625","author":"X Bai","year":"2025","unstructured":"Bai X, Guo YR, Zhao ZM, Li XY, Dai DQ et al (2025) Macrophage polarization in cancer and beyond: from inflammatory signaling pathways to potential therapeutic strategies. Cancer Lett 625:217772","journal-title":"Cancer Lett"},{"issue":"6","key":"1967_CR3","doi-asserted-by":"publisher","first-page":"189224","DOI":"10.1016\/j.bbcan.2024.189224","volume":"1879","author":"M Bates","year":"2024","unstructured":"Bates M, Mohamed BM, Lewis F, O\u2019Toole S, O\u2019Leary JJ (2024) Biomarkers in high grade serous ovarian cancer. Biochim Biophys Acta Rev Cancer 1879(6):189224","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"1967_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N et al (2016) Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol 17(1):218","journal-title":"Genome Biol"},{"issue":"3","key":"1967_CR5","first-page":"229","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL et al (2022) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"1967_CR6","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1158\/0008-5472.CAN-22-3260","volume":"83","author":"K Cao","year":"2023","unstructured":"Cao K, Zhang G, Yang M, Wang Y, He M et al (2023) Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer. Cancer Res 83(13):2171\u20132186","journal-title":"Cancer Res"},{"issue":"14","key":"1967_CR7","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jama.2025.9495","volume":"334","author":"G Caruso","year":"2025","unstructured":"Caruso G, Weroha SJ, Cliby W (2025) Ovarian cancer: a review. JAMA 334(14):1278\u20131291","journal-title":"JAMA"},{"issue":"1","key":"1967_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbrc.2015.05.092","volume":"464","author":"H Chang","year":"2015","unstructured":"Chang H, Dong T, Ma X, Zhang T, Chen Z et al (2015) Spondin 1 promotes metastatic progression through Fak and Src dependent pathway in human osteosarcoma. Biochem Biophys Res Commun 464(1):45\u201350","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"1967_CR9","first-page":"2697","volume":"5","author":"W Dai","year":"2015","unstructured":"Dai W, Huang HL, Hu M, Wang SJ, He HJ et al (2015) microRNA-506 regulates proliferation, migration and invasion in hepatocellular carcinoma by targeting F-spondin 1 (SPON1). Am J Cancer Res 5(9):2697\u20132707","journal-title":"Am J Cancer Res"},{"issue":"3","key":"1967_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41(3):374\u2013403","journal-title":"Cancer Cell"},{"issue":"1","key":"1967_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/1078-0432.CCR-23-2249","volume":"30","author":"Y Drew","year":"2024","unstructured":"Drew Y, Kim JW, Penson RT, O\u2019Malley DM, Parkinson C et al (2024) Olaparib plus Durvalumab, with or without Bevacizumab, as treatment in PARP Inhibitor-na\u00efve platinum-sensitive relapsed ovarian cancer: a phase II multi-cohort study. Clin Cancer Res 30(1):50\u201362","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1967_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41571-024-00937-4","volume":"21","author":"E Ghisoni","year":"2024","unstructured":"Ghisoni E, Morotti M, Sarivalasis A, Grimm AJ, Kandalaft L et al (2024) Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach. Nat Rev Clin Oncol 21(11):801\u2013817","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"1967_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3290","volume":"3","author":"EL Goode","year":"2017","unstructured":"Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W et al (2017) Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer. JAMA Oncol 3(12):e173290","journal-title":"JAMA Oncol"},{"issue":"4","key":"1967_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/path.6400","volume":"265","author":"K Harada","year":"2025","unstructured":"Harada K, Sakamoto N, Kitaoka T, Nakamura Y, Kondo R et al (2025) PI3 expression predicts recurrence after chemotherapy with DNA-damaging drugs in gastric cancer. J Pathol 265(4):472\u2013485","journal-title":"J Pathol"},{"issue":"11","key":"1967_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113426","volume":"42","author":"Y Huang","year":"2023","unstructured":"Huang Y, Xiong C, Wang C, Deng J, Zuo Z et al (2023) p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP. Cell Rep 42(11):113426","journal-title":"Cell Rep"},{"issue":"8","key":"1967_CR16","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.7150\/ijms.107391","volume":"22","author":"X Huang","year":"2025","unstructured":"Huang X, Li X, Shan W, Dou Y, Yu Q et al (2025) Integrating single-cell and bulk RNA sequencing data to explore sphingolipid metabolism molecular signatures in ovarian cancer prognosis: an original study. Int J Med Sci 22(8):1958\u20131977","journal-title":"Int J Med Sci"},{"issue":"5","key":"1967_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13237","volume":"55","author":"Y Huo","year":"2022","unstructured":"Huo Y, Yang J, Zheng J, Xu D, Yang M et al (2022) Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL-6 trans-signalling. Cell Prolif 55(5):e13237","journal-title":"Cell Prolif"},{"issue":"10","key":"1967_CR18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550\u20131558","journal-title":"Nat Med"},{"issue":"4","key":"1967_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR (2018) Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol 15(4):234\u2013248","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1967_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0092-8674(92)90121-R","volume":"69","author":"A Klar","year":"1992","unstructured":"Klar A, Baldassare M, Jessell TM (1992) F-spondin: a gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension. Cell 69(1):95\u2013110","journal-title":"Cell"},{"issue":"21","key":"1967_CR21","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1200\/JCO.23.02076","volume":"42","author":"CN Landen","year":"2024","unstructured":"Landen CN, Buckanovich RJ, Sill MW, Mannel RS, Walker JL et al (2024) Phase I and randomized phase II study of ruxolitinib with frontline neoadjuvant therapy in advanced ovarian cancer: an NRG oncology group study. J Clin Oncol 42(21):2537\u20132545","journal-title":"J Clin Oncol"},{"issue":"21","key":"1967_CR22","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q et al (2017) TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res 77(21):e108\u2013e110","journal-title":"Cancer Res"},{"issue":"9","key":"1967_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.31083\/j.fbl2809199","volume":"28","author":"YB Lin","year":"2023","unstructured":"Lin YB, Xu BH (2023) N6-methyladenosine methyltransferase METTL3 Enhances PTGER2 expression to increase ovarian cancer stemness and chemoresistance. Front Biosci (Landmark Ed) 28(9):199","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"1967_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13048-023-01180-8","volume":"16","author":"R Miyakawa","year":"2023","unstructured":"Miyakawa R, Kobayashi M, Sugimoto K, Endo Y, Kojima M et al (2023) SPON1 is an independent prognostic biomarker for ovarian cancer. J Ovarian Res 16(1):95","journal-title":"J Ovarian Res"},{"issue":"26","key":"1967_CR25","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1016\/j.cell.2024.10.006","volume":"187","author":"G Mollaoglu","year":"2024","unstructured":"Mollaoglu G, Tepper A, Falcomat\u00e0 C, Potak HT, Pia L et al (2024) Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell 187(26):7492-7510.e7422","journal-title":"Cell"},{"issue":"2","key":"1967_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/ijms23020689","volume":"23","author":"S Nagasawa","year":"2022","unstructured":"Nagasawa S, Ikeda K, Shintani D, Yang C, Takeda S et al (2022) Identification of a novel oncogenic fusion gene SPON1-TRIM29 in clinical ovarian cancer that promotes cell and tumor growth and enhances chemoresistance in A2780 cells. Int J Mol Sci 23(2):689","journal-title":"Int J Mol Sci"},{"issue":"636","key":"1967_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abg8402","volume":"14","author":"K Odunsi","year":"2022","unstructured":"Odunsi K, Qian F, Lugade AA, Yu H, Geller MA et al (2022) Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses. Sci Transl Med 14(636):eabg8402","journal-title":"Sci Transl Med"},{"issue":"2","key":"1967_CR28","volume":"2","author":"SI Ou","year":"2021","unstructured":"Ou SI, Xiu J, Nagasaka M, Xia B, Zhang SS et al (2021) Identification of novel CDH1-NRG2\u03b1 and F11R-NRG2\u03b1 fusions in NSCLC plus additional novel NRG2\u03b1 fusions in other solid tumors by whole transcriptome sequencing. JTO Clin Res Rep 2(2):100132","journal-title":"JTO Clin Res Rep"},{"issue":"Suppl 5","key":"1967_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12920-019-0514-7","volume":"12","author":"S Park","year":"2019","unstructured":"Park S, Yoon B, Kim S, Kim S (2019) GENT2: an updated gene expression database for normal and tumor tissues. BMC Med Genomics 12(Suppl 5):101","journal-title":"BMC Med Genomics"},{"issue":"5","key":"1967_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051275","volume":"9","author":"SY Park","year":"2020","unstructured":"Park SY, Kang JY, Lee T, Nam D, Jeon CJ et al (2020) SPON1 can reduce amyloid beta and reverse cognitive impairment and memory dysfunction in Alzheimer\u2019s disease mouse model. Cells 9(5):1275","journal-title":"Cells"},{"issue":"1","key":"1967_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101740","volume":"13","author":"Y Qi","year":"2026","unstructured":"Qi Y, Zhang W, Li X, Shi Y, Qu P (2026) A systematic CRISPR screen reveals an NBL1-mediated Jak\/Stat3 crosstalk to promote ovarian cancer metastasis. Genes Dis 13(1):101740","journal-title":"Genes Dis"},{"issue":"11","key":"1967_CR32","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","volume":"21","author":"M Reina-Campos","year":"2021","unstructured":"Reina-Campos M, Scharping NE, Goldrath AW (2021) CD8(+) T cell metabolism in infection and cancer. Nat Rev Immunol 21(11):718\u2013738","journal-title":"Nat Rev Immunol"},{"issue":"16","key":"1967_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20163850","volume":"20","author":"R Rinc\u00f3n-Rodriguez","year":"2019","unstructured":"Rinc\u00f3n-Rodriguez R, Mena D, Mena J, D\u00edaz-Saldivar P, Guajardo-Correa E et al (2019) F-spondin is the signal by which 2-methoxyestradiol induces apoptosis in the endometrial cancer cell line Ishikawa. Int J Mol Sci 20(16):3850","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1967_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41698-025-00947-0","volume":"9","author":"EPB Rodman","year":"2025","unstructured":"Rodman EPB, Emch MJ, Hou X, Bajaj A, Pearson NA et al (2025) Lestaurtinib\u2019s antineoplastic activity converges on JAK\/STAT signaling to inhibit treatment na\u00efve and therapy resistant forms ovarian cancer. NPJ Precis Oncol 9(1):236","journal-title":"NPJ Precis Oncol"},{"issue":"10","key":"1967_CR35","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.3390\/ijms26104611","volume":"26","author":"B Smolarz","year":"2025","unstructured":"Smolarz B, Biernacka K, \u0141ukasiewicz H, Samulak D, Piekarska E et al (2025) Ovarian cancer-epidemiology, classification, pathogenesis, treatment, and estrogen receptors\u2019 molecular backgrounds. Int J Mol Sci 26(10):4611","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1967_CR36","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/neuonc\/not124","volume":"15","author":"RA Towner","year":"2013","unstructured":"Towner RA, Jensen RL, Vaillant B, Colman H, Saunders D et al (2013) Experimental validation of 5 in-silico predicted glioma biomarkers. Neuro Oncol 15(12):1625\u20131634","journal-title":"Neuro Oncol"},{"key":"1967_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1234894","volume":"14","author":"YM Wang","year":"2023","unstructured":"Wang YM, Cai W, Xue QM, Zhang JY, Zhou L et al (2023) Prognostic role of different PD-L1 expression patterns and tumor-infiltrating lymphocytes in high-grade serous ovarian cancer: a systematic review and meta-analysis. Front Immunol 14:1234894","journal-title":"Front Immunol"},{"issue":"9","key":"1967_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.168792","volume":"9","author":"KM Whately","year":"2024","unstructured":"Whately KM, Sengottuvel N, Edatt L, Srivastava S, Woods AT et al (2024) Spon1+ inflammatory monocytes promote collagen remodeling and lung cancer metastasis through lipoprotein receptor 8 signaling. JCI Insight 9(9):e168792","journal-title":"JCI Insight"},{"key":"1967_CR39","doi-asserted-by":"publisher","first-page":"104001","DOI":"10.1016\/j.ebiom.2022.104001","volume":"79","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Bi M, Guo H, Li M (2022) Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis. EBioMedicine 79:104001","journal-title":"EBioMedicine"},{"issue":"2","key":"1967_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/1568009622666220908092506","volume":"24","author":"M Xu","year":"2024","unstructured":"Xu M, Wen J, Xu Q, Li H, Lin B et al (2024) AHNAK2 promotes the progression of differentiated thyroid cancer through PI3K\/AKT signaling pathway. Curr Cancer Drug Targets 24(2):220\u2013229","journal-title":"Curr Cancer Drug Targets"},{"issue":"8","key":"1967_CR41","doi-asserted-by":"publisher","first-page":"39988","DOI":"10.31083\/CEOG39988","volume":"52","author":"L Xu","year":"2025","unstructured":"Xu L, Zhou L, Wang Y, Jiang X, Cai Y (2025) CCDC80 Induces platinum resistance in ovarian cancer cells through epithelial-mesenchymal transition pathway activation. Clin Exp Obstet Gynecol 52(8):39988","journal-title":"Clin Exp Obstet Gynecol"},{"key":"1967_CR42","doi-asserted-by":"crossref","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H et al (2013) Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 41(Database issue):D955\u2013D961","DOI":"10.1093\/nar\/gks1111"},{"issue":"1","key":"1967_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ygyno.2017.07.007","volume":"147","author":"X Yuan","year":"2017","unstructured":"Yuan X, Zhang J, Li D, Mao Y, Mo F et al (2017) Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis. Gynecol Oncol 147(1):181\u2013187","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1967_CR44","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1038\/s41598-025-87337-5","volume":"15","author":"M Zardab","year":"2025","unstructured":"Zardab M, Grose RP, Kocher HM (2025) AHNAK2: a potential diagnostic biomarker for pancreatic cancer related to cellular motility. Sci Rep 15(1):2934","journal-title":"Sci Rep"},{"issue":"1","key":"1967_CR45","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","volume":"24","author":"M Zhang","year":"2025","unstructured":"Zhang M, Liu C, Tu J, Tang M, Ashrafizadeh M et al (2025) Advances in cancer immunotherapy: historical perspectives, current developments, and future directions. Mol Cancer 24(1):136","journal-title":"Mol Cancer"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01967-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-01967-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01967-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:00:18Z","timestamp":1784685618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-01967-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1967"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-01967-0","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Medical Ethics Committee of Jinshan Hospital of Fudan University (JIEC 2025-S12-02). Clinical trial number: not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants agreed to publish.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"200"}}